The Q3 earnings season for the December 2025 quarter is set to intensify on Monday, February 9, 2026, with a long list of prominent companies across sectors scheduled to announce their financial results. From heavyweight pharmaceutical players and industrial majors to infrastructure firms, jewellery chains, and technology companies, investors will be closely tracking numbers for cues on earnings momentum, margin trends, and sectoral outlook.
This day is particularly important for market participants as results from benchmark-linked companies such as BSE Limited, Zydus Lifesciences, Aurobindo Pharma, Pfizer, and GlaxoSmithKline Pharmaceuticals are expected to shape near-term market sentiment.
Why February 9 Matters for Q3 Earnings
The December quarter traditionally reflects festive demand, export performance, and early signs of margin recovery or stress. For FY26, investors are especially focused on:
- Pharma earnings amid pricing pressure in the US generics market
- Infrastructure and capital goods performance driven by government capex
- Consumer and retail stocks for demand sustainability
- Technology and engineering firms for order inflows and execution updates
With over 70 companies declaring results on the same day, February 9 is among the busiest earnings sessions of this quarter.
Key Companies Announcing Q3 Results on February 9
Market & Financial Services
- BSE Limited
- Cholamandalam Financial Holdings
- Indostar Capital Finance
- Abans Financial Services
- Muthoot Microfin
BSE’s earnings will be keenly watched for transaction revenue trends, average daily turnover (ADTO) growth, and the impact of derivatives volumes.
Pharmaceuticals & Healthcare
- Zydus Lifesciences
- Aurobindo Pharma
- Pfizer
- GlaxoSmithKline Pharmaceuticals
- Neuland Laboratories
- Aarti Pharmalabs
- Supriya Lifescience
- Sun Pharma Advanced Research Company
- Fermenta Biotech
Pharma stocks remain in focus due to USFDA developments, product launches, API pricing trends, and export growth.
Industrials, Engineering & Infrastructure
- Linde India
- The Ramco Cements
- ISGEC Heavy Engineering
- PNC Infratech
- Texmaco Rail and Engineering
- Dynamatic Technologies
- Apollo Micro Systems
- Enviro Infra Engineers
Results from cement and infra companies will give insight into demand recovery, cost pressures, and order book strength.
Consumer, Retail & Lifestyle
- Bata India
- KPR Mill
- Trident
- Jyothy Labs
- Vadilal Industries
- Venkys
Consumer-facing companies are expected to reflect festive-season sales trends and rural demand signals.
Jewellery, Real Estate & Others
- P N Gadgil Jewellers
- Sky Gold and Diamonds
- Embassy Developments
- EIH Associated Hotels
- India Tourism Development Corporation
Jewellery companies will be watched for wedding-season demand, while real estate firms may update on project launches and bookings.
Recent Corporate Update: BEML
On Friday, BEML reported a consolidated net loss of ₹22.38 crore in Q3 FY26, compared with a net profit of ₹24.41 crore in the corresponding quarter last year. Despite the loss, the board declared an interim dividend of ₹2.50 per equity share for FY26, with February 13 fixed as the record date. This mixed performance highlights margin and execution challenges even as shareholder payouts continue.
What Investors Should Watch Today
- Revenue growth vs margins amid cost pressures
- Management commentary on FY26 guidance
- Order inflows and capex visibility for industrial players
- Export and regulatory updates for pharma stocks
- Demand outlook in consumer and discretionary segments
With such a wide range of companies announcing results on February 9, the trading session could see heightened volatility and stock-specific action. Long-term investors should focus not just on headline profit numbers but also on management outlook, balance sheet strength, and sectoral tailwinds. As Q3 earnings unfold, February 9 is shaping up to be a crucial checkpoint for assessing India Inc.’s momentum heading into the final quarter of FY26.